Deep Track Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Deep Track Capital’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-175,400	Closed	-$12.1M	–	77
2024 Q1	$12.1M	Buy	+175,400	New	+$12.1M	0.35%	50

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Deep Track Capital's ITCI Position: Q2 2025 in Review

Deep Track Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,000,000 shares — an estimated $264M sold.

Deep Track Capital first reported a position in ITCI in Q1 2023 and held it in 9 quarters. The position peaked at $264M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Deep Track Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Deep Track Capital sold 2,000,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $264M.
Deep Track Capital first reported a position in Intra-Cellular Therapies Inc. in Q1 2023 and held it in 9 quarters.
Deep Track Capital's Intra-Cellular Therapies Inc. position peaked at $264M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Deep Track Capital's 13F filing for Q2 2025, filed 14 Aug 2025.